BR0314120A - Processo para a diminuição dos nìveis de agregado de proteìna peguilada - Google Patents

Processo para a diminuição dos nìveis de agregado de proteìna peguilada

Info

Publication number
BR0314120A
BR0314120A BR0314120-9A BR0314120A BR0314120A BR 0314120 A BR0314120 A BR 0314120A BR 0314120 A BR0314120 A BR 0314120A BR 0314120 A BR0314120 A BR 0314120A
Authority
BR
Brazil
Prior art keywords
decreasing
pegylated protein
protein aggregate
aggregate levels
levels
Prior art date
Application number
BR0314120-9A
Other languages
English (en)
Other versions
BRPI0314120B1 (pt
BRPI0314120B8 (pt
Inventor
Denis M Boyle
John J Buckley
Gary V Johnson
David E Steinmeyer
Michele Toal
Serdar Aykent
Anurag S Rathore
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/646,798 external-priority patent/US20040048315A1/en
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0314120A publication Critical patent/BR0314120A/pt
Publication of BRPI0314120B1 publication Critical patent/BRPI0314120B1/pt
Publication of BRPI0314120B8 publication Critical patent/BRPI0314120B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/32—Extraction; Separation; Purification by precipitation as complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PROCESSO PARA A DIMINUIçãO DOS NìVEIS DE AGREGADO DE PROTEìNA PEGUILADA". A presente invenção refere-se a métodos recombinantes para fabricação de uma proteína peguilada desejada e agrupamento da mesma. Esse(s) método(s) fornece(m) um produto de polipeptídeo contendo níveis reduzidos de seu agregado agrupado para prover as suas isoformas peguiladas desejadas.
BRPI0314120A 2002-09-20 2003-09-22 processo para diminuição de um nível de agregado de um antagonista de hormônio do crescimento (gh) peguilado e isoformas do mesmo BRPI0314120B8 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US41222702P 2002-09-20 2002-09-20
US60/412,227 2002-09-20
US10/646,798 US20040048315A1 (en) 2002-08-28 2003-08-25 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
US10/646,798 2003-08-25
US66288403A 2003-09-16 2003-09-16
US10/662,884 2003-09-16
PCT/US2003/029546 WO2004026251A2 (en) 2002-09-20 2003-09-22 Process for decreasing aggregate levels of pegylated protein

Publications (3)

Publication Number Publication Date
BR0314120A true BR0314120A (pt) 2005-07-12
BRPI0314120B1 BRPI0314120B1 (pt) 2020-12-29
BRPI0314120B8 BRPI0314120B8 (pt) 2021-05-25

Family

ID=32034217

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0314120A BRPI0314120B8 (pt) 2002-09-20 2003-09-22 processo para diminuição de um nível de agregado de um antagonista de hormônio do crescimento (gh) peguilado e isoformas do mesmo

Country Status (17)

Country Link
EP (1) EP1545428B1 (pt)
JP (1) JP4633463B2 (pt)
KR (1) KR101120130B1 (pt)
AT (1) ATE453662T1 (pt)
AU (1) AU2003272585B2 (pt)
BR (1) BRPI0314120B8 (pt)
CA (1) CA2498886C (pt)
DE (1) DE60330787D1 (pt)
DK (1) DK1545428T3 (pt)
ES (1) ES2337041T3 (pt)
HK (1) HK1079798B (pt)
IL (1) IL167538A (pt)
MX (1) MXPA05003121A (pt)
PL (1) PL212726B1 (pt)
PT (1) PT1545428E (pt)
SI (1) SI1545428T1 (pt)
WO (1) WO2004026251A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007522198A (ja) * 2004-02-09 2007-08-09 ファルマシア コーポレーション 化学修飾されたヒト成長ホルモン受容体アンタゴニスト結合体
GB2438760A (en) * 2004-12-22 2007-12-05 Ambrx Inc Methods for expression and purification of recombinant human growth hormone
WO2011018515A1 (en) * 2009-08-14 2011-02-17 Novo Nordisk Health Care Ag Method of purifying pegylated proteins
EP3388443A1 (en) * 2011-05-13 2018-10-17 Biogen MA Inc. Methods of preventing and removing trisulfide bonds
CA2838814A1 (en) * 2011-08-25 2013-02-28 F.Hoffmann-La Roche Ag Cation and anion exchange chromatography method
SG11202006140TA (en) * 2017-12-29 2020-07-29 Hoffmann La Roche Process for providing pegylated protein composition
CN112107880B (zh) * 2020-09-16 2022-08-09 珠海中科先进技术研究院有限公司 一种低共熔混合物及利用其萃取鲟鱼鱼籽蛋白质的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5153265A (en) * 1988-01-20 1992-10-06 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
AU6255096A (en) * 1995-06-07 1996-12-30 Mount Sinai School Of Medicine Of The City University Of New York, The Pegylated modified proteins
CA2658039A1 (en) * 1995-09-21 1997-03-27 Genentech, Inc. Human growth hormone variants
SE9802454D0 (sv) * 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
SE9904502D0 (sv) * 1999-12-09 1999-12-09 Pharmacia & Upjohn Ab Production of peptides

Also Published As

Publication number Publication date
EP1545428B1 (en) 2009-12-30
JP4633463B2 (ja) 2011-02-16
JP2006516021A (ja) 2006-06-15
HK1079798B (zh) 2010-11-19
PL375443A1 (en) 2005-11-28
ATE453662T1 (de) 2010-01-15
EP1545428A2 (en) 2005-06-29
CA2498886A1 (en) 2004-04-01
SI1545428T1 (sl) 2010-03-31
ES2337041T3 (es) 2010-04-20
WO2004026251A2 (en) 2004-04-01
AU2003272585A1 (en) 2004-04-08
CA2498886C (en) 2013-06-25
PL212726B1 (pl) 2012-11-30
BRPI0314120B1 (pt) 2020-12-29
KR101120130B1 (ko) 2012-04-18
HK1079798A1 (en) 2006-04-13
BRPI0314120B8 (pt) 2021-05-25
DK1545428T3 (da) 2010-05-03
AU2003272585B2 (en) 2009-12-10
DE60330787D1 (de) 2010-02-11
EP1545428A4 (en) 2006-03-01
MXPA05003121A (es) 2005-06-22
IL167538A (en) 2015-10-29
KR20050046011A (ko) 2005-05-17
WO2004026251A3 (en) 2004-09-02
PT1545428E (pt) 2010-02-25

Similar Documents

Publication Publication Date Title
HK1079798A1 (en) Process for decreasing aggregate levels of pegylated protein
SG166001A1 (en) Methods of generating and screening for proteases with altered specificity
WO1998024804A3 (en) INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
ATE513917T1 (de) Bakterielle expression von proteaseinhibitoren und varianten davon
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
DE60206885D1 (de) Agarase und gen dafür
DE3587875T2 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
DE69731463D1 (de) Rekombinante ribonuklease proteine
HK1077074A1 (en) Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
WO2001016324A3 (en) Methods and compositions of a novel serine protease inhibitor
TW200502248A (en) Process for decreasing aggregate levels of pegylated protein
ATE416260T1 (de) Verfahren zur überwachung und modulierung von proteinfaltung
DE60128367D1 (de) Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren
ATE435914T1 (de) Induktion der blütenbildung
ATE380247T1 (de) Verfahren zur gesteuerten nach-ernte-produktion von proteinen in pflanzen
DE60200241D1 (de) Prozess zur Herstellung von benzopyran carboxamid
WO2005056770A3 (en) Band 5: a human testis specific protein

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/09/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF